Review




Structured Review

Tillotts Pharma AG balanced block randomisation
Characteristics of included studies [ordered by study ID]
Balanced Block Randomisation, supplied by Tillotts Pharma AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/balanced+block+randomisation/balanced+block+randomisation/pmc04170890-309-2-8
Average 90 stars, based on 1 article reviews
balanced block randomisation - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Omega 3 fatty acids for prevention and treatment of cardiovascular disease"

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

Journal: The Cochrane database of systematic reviews

doi: 10.1002/14651858.CD003177.pub2

Characteristics of included studies [ordered by study ID]
Figure Legend Snippet: Characteristics of included studies [ordered by study ID]

Techniques Used: Blocking Assay, Control, Activity Assay


Figure Legend Snippet:

Techniques Used: Control, Capsules, Clinical Proteomics


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Blocking Assay, Control, Capsules, Labeling


Figure Legend Snippet:

Techniques Used: Generated, Control


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Blocking Assay, Control


Figure Legend Snippet:

Techniques Used: Control


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Sequencing, Control, Capsules


Figure Legend Snippet:

Techniques Used: Control


Figure Legend Snippet:

Techniques Used: Generated, Control, Capsules


Figure Legend Snippet:

Techniques Used: Generated, Control, Capsules


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Control, Capsules, Membrane


Figure Legend Snippet:

Techniques Used: Control, Membrane, Activity Assay


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Capsules, Control, Clinical Proteomics


Figure Legend Snippet:

Techniques Used: Generated, Control, Capsules


Figure Legend Snippet:

Techniques Used: Software, Control, Capsules, Membrane


Figure Legend Snippet:

Techniques Used: Software, Control, Capsules, Membrane


Figure Legend Snippet:

Techniques Used: Control, Capsules, Clinical Proteomics


Figure Legend Snippet:

Techniques Used: Control, Capsules, Clinical Proteomics


Figure Legend Snippet:

Techniques Used: Blocking Assay, Control, Capsules


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Control


Figure Legend Snippet:

Techniques Used: Control


Figure Legend Snippet:

Techniques Used: Capsules, Control


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Generated, Produced, Filtration, Control, Emulsion


Figure Legend Snippet:

Techniques Used: Control, Clinical Proteomics


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Selection, Control, Capsules


Figure Legend Snippet:

Techniques Used: Labeling, Capsules, Control, Clinical Proteomics


Figure Legend Snippet:

Techniques Used: Control, Capsules, Clinical Proteomics


Figure Legend Snippet:

Techniques Used: Control, Capsules, Clinical Proteomics


Figure Legend Snippet:

Techniques Used: Control, Capsules


Figure Legend Snippet:

Techniques Used: Generated, Sequencing, Control, Capsules


Figure Legend Snippet:

Techniques Used: Clinical Proteomics, Control

Related Articles

Blocking Assay:

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease
Article Snippet: .. Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , . .. Participants , N: 39 int., 39 control Level of risk for CVD: low (established Crohn’s disease, in remission) Male: 51.3% int., 48.7% control Median age, sd: 34 int, 39 control Age range: 18-67 int., 20-65 control Smokers: 36% int., 33% control Hypertension: Not stated Location: Italy , .



Similar Products

90
StatsDirect ltd block-balanced randomisation
Block Balanced Randomisation, supplied by StatsDirect ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/balanced+block+randomisation/block+balanced+randomisation/pmc06429886-59-1-10
Average 90 stars, based on 1 article reviews
block-balanced randomisation - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Catalent Pharma Solutions block balanced randomisation codes
Block Balanced Randomisation Codes, supplied by Catalent Pharma Solutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/balanced+block+randomisation/block+balanced+randomisation+codes/pmc06537970__bmjopen___2019___029554__draft_revisions-706-32-43
Average 90 stars, based on 1 article reviews
block balanced randomisation codes - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bilcare Inc balanced block randomisation scheme
Balanced Block Randomisation Scheme, supplied by Bilcare Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/balanced+block+randomisation/balanced+block+randomisation+scheme/pm27109816-64-11-17
Average 90 stars, based on 1 article reviews
balanced block randomisation scheme - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Tillotts Pharma AG balanced block randomisation
Characteristics of included studies [ordered by study ID]
Balanced Block Randomisation, supplied by Tillotts Pharma AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/balanced+block+randomisation/balanced+block+randomisation/pmc04170890-309-2-8
Average 90 stars, based on 1 article reviews
balanced block randomisation - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of included studies [ordered by study ID]

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet: Characteristics of included studies [ordered by study ID]

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Activity Assay

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Capsules, Labeling

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Sequencing, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Membrane, Activity Assay

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Capsules, Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Software, Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Software, Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Capsules, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Produced, Filtration, Control, Emulsion

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Selection, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Labeling, Capsules, Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Sequencing, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Clinical Proteomics, Control